- Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis
-
Hsu PY, Wei YJ, Lee JJ, Niu SW, Huang JC, Hsu CT, Jang TY, Yeh ML, Huang CI, Liang PC, Lin YH, Hsieh MY, Hsieh MH, Chen SC, Dai CY, Lin ZY, Chen SC, Huang JF, Chang JM, Hwang SJ, Chuang WL, Huang CF, Chiu YW, Yu ML
- KMID: 2511467
- Clin Mol Hepatol.
- 2021 Jan;27(1):186-196.
- doi: 10.3350/cmh.2020.0180
Background/Aims: Direct‐acting antivirals (DAAs) have been approved for hepatitis C virus (HCV) treatment in patients with end-stage renal disease (ESRD) on hemodialysis. Nevertheless, the complicated comedications and their potential drug-drug... -
- CITED
-
- Close
- SHARE
-
- Close
